Potential Inhibitory Effect of LASSBio-596, a New Thalidomide Hybrid, on Inflammatory Corneal Angiogenesis in Rabbits
Author(s) -
João Crispim Moraes Lima Ribeiro,
Francisco Vagnaldo Fechine,
Mariana Zaira M.L. Ribeiro,
Eliezer J. Barreiro,
Lı́dia Moreira Lima,
Nágila Maria Pontes Silva Ricardo,
Maria Elisabete Amaral de Moraes,
Manoel Odorico de Moraes
Publication year - 2012
Publication title -
ophthalmic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 54
eISSN - 1423-0259
pISSN - 0030-3747
DOI - 10.1159/000337137
Subject(s) - dexamethasone , angiogenesis , cauterization , cornea , neovascularization , chemistry , medicine , endocrinology , surgery , ophthalmology
Evaluate the effect of LASSBio-596, structurally designed as a new hybrid of thalidomide, on inflammatory corneal angiogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom